150 related articles for article (PubMed ID: 1965982)
1. Generation and metabolism of leukotrienes in granulocytes of patients with cystic fibrosis.
Saak A; Schönfeld W; Knöller J; Steinkamp G; von der Hardt H; König W
Int Arch Allergy Appl Immunol; 1990; 93(2-3):227-36. PubMed ID: 1965982
[TBL] [Abstract][Full Text] [Related]
2. [LTB4-metabolism and histamine liberation by granulocytes in the disease pattern of cystic fibrosis (CF)].
Saak A; Schönfeld W; König W; von der Hardt H
Pneumologie; 1991 Nov; 45(11):913-23. PubMed ID: 1722312
[TBL] [Abstract][Full Text] [Related]
3. Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate.
Salari H; Borgeat P; Fournier M; Hebert J; Pelletier G
J Exp Med; 1985 Dec; 162(6):1904-15. PubMed ID: 2415659
[TBL] [Abstract][Full Text] [Related]
4. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
Williams JD; Lee TH; Lewis RA; Austen F
J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
[TBL] [Abstract][Full Text] [Related]
5. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanisms of granulocyte dysfunctions in severely burned patients--evidence for altered leukotriene generation.
Köller M; König W; Brom J; Erbs G; Müller FE
J Trauma; 1989 Apr; 29(4):435-45. PubMed ID: 2540344
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene generation in patients with multiple injuries.
Schönfeld W; Knöller J; Joka T; Obertacke U; König W
J Trauma; 1992 Dec; 33(6):799-806. PubMed ID: 1474618
[TBL] [Abstract][Full Text] [Related]
8. Effect of sodium fluoride on the generation of lipoxygenase products from human polymorphonuclear granulocytes, mononuclear cells and platelets--indication for the involvement of G proteins.
Brom C; Köller M; Brom J; König W
Immunology; 1989 Oct; 68(2):240-6. PubMed ID: 2553586
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages.
Laviolette M; Carreau M; Coulombe R; Cloutier D; Dupont P; Rioux J; Braquet P; Borgeat P
J Immunol; 1988 Sep; 141(6):2104-9. PubMed ID: 2844895
[TBL] [Abstract][Full Text] [Related]
10. Release of arachidonic acid metabolites by human monocytes or lymphocytes: effect of treatment with interferon on stimulation by phorbol ester or calcium ionophore.
Hoffman T; Lizzio EF; Ting A; Marshall LA; Bonvini E; Jennings MK
Clin Immunol Immunopathol; 1987 Jul; 44(1):82-92. PubMed ID: 2439242
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids suppress the enhanced production of 5-lipoxygenase products from polymorph neutrophil granulocytes in cystic fibrosis.
Keicher U; Koletzko B; Reinhardt D
Eur J Clin Invest; 1995 Dec; 25(12):915-9. PubMed ID: 8719931
[TBL] [Abstract][Full Text] [Related]
12. Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid.
Raulf M; König W
Immunology; 1988 May; 64(1):51-9. PubMed ID: 2838420
[TBL] [Abstract][Full Text] [Related]
13. Influence of hypoxia on 5-lipoxygenase pathway in rat alveolar macrophages.
Ohwada A; Kira S; Yamashita T
Prostaglandins Leukot Essent Fatty Acids; 1990 Jan; 39(1):69-73. PubMed ID: 2160085
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products.
Henderson WR; Harley JB; Fauci AS
Immunology; 1984 Apr; 51(4):679-86. PubMed ID: 6323307
[TBL] [Abstract][Full Text] [Related]
15. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products.
Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA
Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 5- and 15-lipoxygenase activities in blood and alveolar leukocyte preparations from normal subjects and patients with eosinophilia.
Laviolette M; Picard S; Braquet P; Borgeat P
Prostaglandins Leukot Med; 1986 Aug; 23(2-3):191-9. PubMed ID: 3020586
[TBL] [Abstract][Full Text] [Related]
17. Ionophore A23187-induced leukotriene biosynthesis in equine granulocytes-neutrophils, but not eosinophils require exogenous arachidonic acid.
Lindberg A; Tornhamre S; Mugnai S; Lindgren J
Biochim Biophys Acta; 1998 Mar; 1391(2):247-55. PubMed ID: 9555040
[TBL] [Abstract][Full Text] [Related]
18. Anthralin (1,8-dihydroxyanthrone) is a potent inhibitor of leukotriene production and LTB4-omega oxidation by human neutrophils.
Schröder JM
J Invest Dermatol; 1986 Nov; 87(5):624-9. PubMed ID: 3021863
[TBL] [Abstract][Full Text] [Related]
19. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of bone resorption by lipoxygenase metabolites of arachidonic acid.
Meghji S; Sandy JR; Scutt AM; Harvey W; Harris M
Prostaglandins; 1988 Aug; 36(2):139-49. PubMed ID: 2847250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
